|
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'24 | $-0.35 | $-0.41 | -18.3% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'24 | - | $476M | - |
Market Data
NTRA is currently trading at $188.00, giving NTRA a market cap of 28.53B. Today's range spans $204.04–$213.30, with shares opening at $208.83 and moving down $7.50 (3.8%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL).
Over the past year NTRA has traded between $125.38 and $256.36 - the current price is +49.9% off the 52-week low and -26.7% from the high.
NTRA is showing a SELL signal (27/100) with neutral sentiment (-/100). Price: $188.00 (in the middle of its 52-week range within $125.38–$256.36). At 28.53B in Healthcare market cap, a bearish technical read accompanied by negative sentiment often marks the beginning of an earnings revision cycle downward - active managers trim before the revisions become consensus, compounding the selling pressure.
When a large-cap Healthcare name with 28.53B in capitalization prints a SELL signal (27/100) alongside neutral news sentiment (-/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $188.00 (in the middle of its 52-week range in the $125.38–$256.36 range), the structural support levels are where that sponsorship question gets answered.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines